136 related articles for article (PubMed ID: 18772578)
1. [A case of probable autoimmune hepatitis from which the persistence of hepatitis A IgM antibody, and the improvement was pathologically obtained by ursodeoxycholic acid medication].
Matsushita M; Takemura T; Imai Y; Takimoto K; Kuchide M; Kajikawa H; Kojima Y; Shimamoto F; Yamauchi H; Matsuyama K; Yoshikawa T
Nihon Shokakibyo Gakkai Zasshi; 2008 Sep; 105(9):1367-74. PubMed ID: 18772578
[TBL] [Abstract][Full Text] [Related]
2. Prolonged acute hepatitis A mimicking autoimmune hepatitis.
Mikata R; Yokosuka O; Imazeki F; Fukai K; Kanda T; Saisho H
World J Gastroenterol; 2005 Jun; 11(24):3791-3. PubMed ID: 15968741
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.
Li CP; Tong MJ; Hwang SJ; Luo JC; Co RL; Tsay SH; Chang FY; Lee SD
J Gastroenterol Hepatol; 2000 Jan; 15(1):95-8. PubMed ID: 10719755
[TBL] [Abstract][Full Text] [Related]
4. A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Amano N; Sato S; Murata A; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Harada K; Genda T
Clin J Gastroenterol; 2020 Feb; 13(1):79-82. PubMed ID: 31286423
[TBL] [Abstract][Full Text] [Related]
5. [A case of autoimmune hepatitis followed-up with an oral administration of ursodeoxycholic acid].
Sugimoto M; Saito Y; Akimoto T; Kato H; Miyashita M; Shinohara M; Shinohara M; Wakui T; Hirata A; Saito N; Nonaka H
Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1232-7. PubMed ID: 15570873
[No Abstract] [Full Text] [Related]
6. Case of primary biliary cirrhosis-autoimmune hepatitis overlap which manifested after delivery.
Monoe K; Takahashi A; Katsushima F; Kanno Y; Saito H; Abe K; Yokokawa J; Ohira H
Intern Med; 2011; 50(12):1299-301. PubMed ID: 21673465
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
Kawabata H; Kawakatsu Y; Inoue N; Okazaki Y; Sone D; Yamaguchi K; Ueda Y; Hitomi M; Miyata M; Motoi S; Enoki Y; Minamikawa T
Intern Med; 2020; 59(11):1401-1405. PubMed ID: 32475907
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
10. A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia.
Shibata M; Morizane T; Tanaka A; Onozuka Y; Uchida T; Gershwin ME; Mitamura K
J Gastroenterol Hepatol; 2001 Jul; 16(7):830-5. PubMed ID: 11446897
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment.
Floreani A; Baragiotta A; Guido M
Dig Liver Dis; 2003 Feb; 35(2):128-9. PubMed ID: 12747633
[No Abstract] [Full Text] [Related]
12. The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
Koçak N; Saltik IN
Am J Gastroenterol; 2001 Feb; 96(2):610-1. PubMed ID: 11232728
[No Abstract] [Full Text] [Related]
13. Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Duclos-Vallée JC; Di Martino V; Cazier A; Ballot E; Johanet C; Yamamoto AM; Emile JF; Guettier C; Coutarel P; Cadranel JF
Gastroenterol Clin Biol; 2005 Nov; 29(11):1173-6. PubMed ID: 16505766
[TBL] [Abstract][Full Text] [Related]
14. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
[No Abstract] [Full Text] [Related]
15. Examining the increased IgM production and ursodeoxycholic acid treatment in PBC.
Lazaridis KN; Larusso NF
Gastroenterology; 2005 Feb; 128(2):498-500. PubMed ID: 15685560
[No Abstract] [Full Text] [Related]
16. Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis.
Wang SB; Wang JH; Zheng RH; Zhong BH; Chen MH
Hepatogastroenterology; 2010; 57(98):326-9. PubMed ID: 20583436
[TBL] [Abstract][Full Text] [Related]
17. Acute seronegative autoimmune hepatitis.
Ozaslan E; Samsar U; Erden E
Hepatogastroenterology; 2010; 57(98):334-5. PubMed ID: 20583438
[TBL] [Abstract][Full Text] [Related]
18. Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
Bae SH; Kim JS; Kim DH
J Korean Med Sci; 2006 Aug; 21(4):758-60. PubMed ID: 16891827
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis.
Chazouillères O; Poupon R
Hepatology; 2002 Oct; 36(4 Pt 1):1026-7; author reply 1027. PubMed ID: 12297861
[No Abstract] [Full Text] [Related]
20. Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter.
Omori K; Yoshida K; Yokota M; Daa T; Kan M
Clin J Gastroenterol; 2016 Oct; 9(5):312-8. PubMed ID: 27503128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
